Cookie-Settings

We use cookies to give you the best experience possible with our website and to improve our communication with you. We consider your selection and will only use the data you have approved us to gather.

These cookies help making a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. With this information we can constantly improve the experience we offer on our website.

These cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

DE
  • Home
  • About medac
  • Information for patients
  • Healthcare professionals
  • Products
  • Career opportunities
  • Media
  • medac News

    medac News

    News

    Read more

    medac statement on Coronavirus (SARS-CoV-2)

    At this moment in time, and after consultation of the competent authorities, we do not foresee any interruptions in production and therefore no supply...

    Read more

    TrecondiĀ® - the new original from medac

    After 20 years of intensive research and development activity in the field of haematology and oncology, medac received EU-wide marketing authorisation...

    Read more

    NEW in the Haematology Portfolio: Carmustin Obvius

    With the launch of Carmustin Obvius in Germany, the Haematology Portfolio has been augmented by an additional substance.

    The active substance...

    Read more

    Delivery failure urokinase

    Urokinase medac is not available at the moment. At present, work is underway on a new production of the drug in order to provide patients with...

    Read more

    Medac at the EBMT 2019

    Innovative conditioning therapy for MDS and AML

    Nach oben